Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurelien Amiot

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2025
Author's reply: Comment on "Severe enterocolitis associated with phosphatidylinositol 3-kinase delta inhibitors: A multicentre cohort study"Aurelien Amiot
Alimentary Pharmacology & Therapeutics|February 13, 2020
Letter: new insights on tofacitinib dose de-escalationAurelien Amiot
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: a long way to go before precision medicineAurelien Amiot
Alimentary Pharmacology & Therapeutics|April 1, 2020
Letter: immunogenicity of infliximab-ready for routine prediction?Aurelien Amiot
Alimentary Pharmacology & Therapeutics|October 5, 2020
Letter: long-term outcomes of patients with acute severe ulcerative colitis after intravenous steroid therapy-authors' replyAurelien Amiot, Robert Salameh
Alimentary Pharmacology & Therapeutics|May 24, 2021
Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' replyJenny Tannoury, Aurelien Amiot
Therapeutic Advances in Gastroenterology|March 3, 2015
Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseasesAurelien Amiot, Laurent Peyrin-Biroulet
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: ustekinumab during pregnancy - reassuring but still not enoughAurelien Amiot, Antoine Meyer, Franck Carbonnel
Gastroenterology Clinics of North America|November 22, 2011
Nutritional support in the severely compromised motility patient: when and how?Francisca Joly, Aurelien Amiot, Bernard Messing
Alimentary Pharmacology & Therapeutics|August 8, 2022
Letter: to switch or not to switch, that is the questionClément Bresteau, Antoine Martin, Aurelien Amiot
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2025
Author's reply: Comment on "Severe enterocolitis associated with phosphatidylinositol 3-kinase delta inhibitors: A multicentre cohort study"Aurelien Amiot
Alimentary Pharmacology & Therapeutics|February 13, 2020
Letter: new insights on tofacitinib dose de-escalationAurelien Amiot
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: a long way to go before precision medicineAurelien Amiot
Alimentary Pharmacology & Therapeutics|April 1, 2020
Letter: immunogenicity of infliximab-ready for routine prediction?Aurelien Amiot
Alimentary Pharmacology & Therapeutics|October 5, 2020
Letter: long-term outcomes of patients with acute severe ulcerative colitis after intravenous steroid therapy-authors' replyAurelien Amiot, Robert Salameh
Alimentary Pharmacology & Therapeutics|May 24, 2021
Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' replyJenny Tannoury, Aurelien Amiot
Therapeutic Advances in Gastroenterology|March 3, 2015
Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseasesAurelien Amiot, Laurent Peyrin-Biroulet
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: ustekinumab during pregnancy - reassuring but still not enoughAurelien Amiot, Antoine Meyer, Franck Carbonnel
Gastroenterology Clinics of North America|November 22, 2011
Nutritional support in the severely compromised motility patient: when and how?Francisca Joly, Aurelien Amiot, Bernard Messing
Alimentary Pharmacology & Therapeutics|August 8, 2022
Letter: to switch or not to switch, that is the questionClément Bresteau, Antoine Martin, Aurelien Amiot
Pageof 8